World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
34407
World Ranking
8625
National Ranking
4450

Richard Gorlick publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Gorlick sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 500 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Gorlick D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Gorlick sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard Gorlick is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research is primarily focused on fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a specific concentration in Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Neurology.

The main topics addressed in their work include:

  • Sarcoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Neuroblastoma Research and Treatments
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Lymphoma Diagnosis and Treatment

Recent publications by Richard Gorlick cover several aspects of osteosarcoma and cancer therapy, including:

  • Advancing therapy for osteosarcoma, 2021, Nature Reviews Clinical Oncology
  • Osteosarcoma, 2022, Nature Reviews Disease Primers
  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma, 2020, JAMA Oncology
  • Immuno-genomic landscape of osteosarcoma, 2020, Nature Communications
  • The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models, 2021, Clinical Cancer Research

Frequent co-authors in Gorlick's research include:

  • Jonathan Gill
  • Wendong Zhang
  • Katherine A. Janeway
  • Zhongting Zhang
  • Douglas J. Harrison

Richard Gorlick has contributed to publications in several notable journals with multiple works in venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Clinical Cancer Research
  • Nature Medicine

In addition to journal articles, Gorlick has published books through Springer Nature, including:

  • Current Advances in the Science of Osteosarcoma, 2020
  • Current Advances in Osteosarcoma, 2020

Best Publications

  • Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

    Michael S. Isakoff;Stefan S. Bielack;Paul S Meltzer;Richard Gorlick

  • The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.

    Chand Khanna;Xiaolin Wan;Seuli Bose;Ryan Cassaday

  • Biology and Therapeutic Advances for Pediatric Osteosarcoma

    Neyssa Marina;Mark Gebhardt;Lisa Teot;Richard Gorlick

  • Current and future therapeutic approaches for osteosarcoma

    Douglas J. Harrison;David S. Geller;Jonathan D. Gill;Valerae O. Lewis

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Osteosarcoma: a review of diagnosis, management, and treatment strategies.

    David S. Geller;Richard Gorlick

  • The pediatric preclinical testing program: description of models and early testing results.

    Peter J. Houghton;Christopher L. Morton;Chandra Tucker;Debbie Payne

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Advancing therapy for osteosarcoma.

    Jonathan Gill;Richard Gorlick

  • Chemotherapy resistance in osteosarcoma: current challenges and future directions

    Alexander J Chou;Richard Gorlick

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-β-Catenin Pathway

    Bang H. Hoang;Tadahiko Kubo;John H. Healey;Rui Yang

  • Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

    Paul A. Meyers;Richard Gorlick;Glenn Heller;Ephraim Casper

  • Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma

    Richard Gorlick;Andrew G. Huvos;Glenn Heller;Alex Aledo

  • Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

    Debabrata Banerjee;Philipp Mayer-Kuckuk;Gina Capiaux;Gina Capiaux;Tulin Budak-Alpdogan

  • Therapy for osteosarcoma: where do we go from here?

    Alexander J. Chou;David S. Geller;Richard Gorlick

  • EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    J. S. Whelan;S. S. Bielack;N. Marina;S. Smeland

  • New targets and approaches in osteosarcoma.

    Jonathan Gill;Manpreet K. Ahluwalia;Manpreet K. Ahluwalia;David Geller;David Geller;Richard Gorlick;Richard Gorlick

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
John M. Maris
John M. Maris Children's Hospital of Philadelphia
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Paul A. Meyers
Paul A. Meyers Memorial Sloan Kettering Cancer Center
John H. Healey
John H. Healey Memorial Sloan Kettering Cancer Center
Mark Krailo
Mark Krailo University of Southern California
Andrew G. Huvos
Andrew G. Huvos Memorial Sloan Kettering Cancer Center
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine
Holcombe E. Grier
Holcombe E. Grier Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, several related online degrees offer flexible, affordable pathways into healthcare. Medical billing and coding is a popular entry point, allowing students to gain essential administrative skills. For those concerned about tuition, look for medical billing and coding online courses cost to find the most budget-friendly programs.

Nursing remains one of the most in-demand professions in the U.S. Aspiring nurses can take advantage of the cheapest online nursing program options to begin working in patient care more quickly and affordably. For advanced roles, nurse practitioner programs provide an excellent route to higher-paying, responsible positions with expanded clinical authority.

Those aiming for leadership or research roles should consider doctoral studies. Explore online phd nursing programs that combine scientific inquiry, policy, and education. All these paths offer flexible online learning formats, opening up new career opportunities and advancement in the healthcare sector.

Best Scientists Citing Richard Gorlick

Trending Scientists

Recently Published Articles